Skip to Main Content

Advertisement

Skip Nav Destination

Tumor Rejection by in Vivo Administration of Anti-CD25 (Interleukin-2 Receptor α) Monoclonal Antibody1

Cancer Res (1999) 59 (13): 3128–3133.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal